Wen Ding

@wyd20.bsky.social

Paediatric nephrologist in Bristol, progressing kidney gene 🧬therapy, mum of boys, loves ballet/ gymnastics/ dance

Kidney disease affects 1 in 10 of the UK population and has largely been overlooked in the UK 10 Year Health Plan. Please sign this petition by Thursday 9th October to emphasise the importance of a national strategy for kidney disease. www.ukkidney.org/prime-minist...

Add Your Name: Call on the Prime Minister to Tackle Kidney Disease

Kidney disease affects more than 7 million people in the UK, yet was largely overlooked in the Government’s new 10-year health plan for the NHS. Without action, it will place an unsustainable burden o...

ukkidney.org

What an exciting time to be a nephrologist. Yet another really promising therapy for IgA. Decreases proteinuria significantly, likely will be spoilt for choice soon but how will be choose the right meds for the right patient?

NEJM.org@nejm.org · last yr.

Among patients with IgA nephropathy, treatment with iptacopan, which inhibits the alternative complement pathway, resulted in a significant reduction in proteinuria as compared with placebo. Full APPLAUSE-IgAN trial results and Research Summary: nej.md/3UmrOkh #MedSky #Nephrology

Iptacopan in IgA Nephropathy

A Research Summary based on Perkovic V et al. | 10.1056/NEJMoa2410316 | Published on October 25, 2024

Not apologising for posting this paper twice as really excited about ProtGPS. Logical next step in protein modelling after the success of alphafold2. Not only will help predict pathogenicity of genetic variants but can incorporate elements for subcellular compartmentalisation in gene therapy design

Whitehead Institute@whiteheadinstitute.bsky.social · last yr.

Researchers in the Young Lab at Whitehead Institute and the Barzilay Lab in MIT's CSAIL have developed ProtGPS, a machine learning model that predicts which cellular compartments a protein will reside in. This tool could inform the development of more effective therapies. shorturl.at/5KdVE

Gene editing technology began by people studying salt marshes. Ozempic began by folks studying the venom of Gila Monsters. Support for basic science has empowered us to understand our world. Tethering it to applications health has transformed and saved countless lives.

Chronic Kidney Disease is rising in prevalence--I have signed this petition for the World Health Organisation to recognise kidney health as a priority, do consider signing to prioritise preventing premature death from kidney disease #nephsky #medsky #pedsky

Fernanda Arce-Amaré@ferarceamare.bsky.social · 2y ago

Guatemala is leading a historic effort at the @who.int to recognize kidney disease as a global health priority. This will drive global strategies to improve care and reduce the burden of kidney disease. Sign the petition: ow.ly/a7J350Tfpjp #KidneyHealthMatters #UHCDay TY @momenabbasi.bsky.social

#PedSky appreciation post: Dr. Weyand’s posts are why I now check ferritin/CRP for every anemia screen (w CBC + retic)! I’ve caught so many w single digit ferritin levels even if Hgb is “normal” 😱 It’s also an issue in “picky eaters” even if they’re not menstruating

Shematologist, MD@shematologist.medsky.social · 2y ago

Just your regular reminder that iron deficiency affects ~40% of 12-21 yo females and still no one cares. jamanetwork.com/journals/jam...

Some papers are very difficult to read but that doesn’t necessarily mean they're deeper than other papers. Authors must work very hard to make their story easy to read and understand by others. Or as Stephen King says: "the shorter the book, the less bullshit".

Bild

1/9 🤔 Why doesn't an elevated BUN lead to extreme thirst? If increased serum osmolarity compels us to seek water, uremia should be a significant driver of this craving. And yet, it isn't. Let's examine why.

❤️Great visual abstract of the original ISKDC study for NS from 50 years ago! high dose steroids magically melts away childhood NS but can we do better? In an ideal world: ✔️equally efficacious induction therapy ✔️minimal side effects ✔️cost effective-equal access in LMICs where NS incidence higher

Michelle Rheault, MD@rheaultm.bsky.social · 2y ago

Know your Ped Neph History! In the 1970s, the International Study of Kidney Disease in Children completed a trial where every child (3mo - <16 years) who presented with nephrotic syndrome was biopsied. We still quote these numbers to families today. Visual Abstract 👉 shop.lww.com/Handbook-of-...

Visual Abstract for ISKDC study published in 1981. 521 children were enrolled with first onset nephrotic syndrome and treated with standard prednisone. 93.1% responded to steroids. Of those, 91.8% had minimal change disease.